SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond

Expert Rev Respir Med. 2022 May;16(5):499-502. doi: 10.1080/17476348.2022.2057299. Epub 2022 Apr 1.

Authors

Sean Wei Xiang Ong^{1

2}, Travis Chia¹, Barnaby Edward Young^{1

2

3}

Affiliations

¹ National Centre for Infectious Diseases, Singapore.
² Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
³ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

No abstract available

Keywords: COVID-19; SARS-CoV-2; breakthrough infection; vaccination.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Humans
SARS-CoV-2
Viral Vaccines*

Substances

Viral Vaccines

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

Barnaby Young was supported by grants from the National Medical Research Council (REF: COVID19RF-018, COVID19RF-0008).